WHC is still in active development. Read this to understand our approach.
depiction of QVDSEJDULKLHCG-UHFFFAOYSA-N.svg
isomerdesign

Psilocybin

Check on isomerdesign

pubchem

Psilocybine

Check on pubchem

druglab

Psilocybine

Check on druglab

Data

InChI: InChI=1S/C12H17N2O4P/c1-14(2)7-6-9-8-13-10-4-3-5-11(12(9)10)18-19(15,16)17/h3-5,8,13H,6-7H2,1-2H3,(H2,15,16,17)

Synonyms: 3-[2-(Dimethylamino)ethyl]-4-indolol, phosphate ester,Constituent of Magic mushrooms,SCHEMBL158945,DSSTox_RID_83093,ZINC1530830,Indocybin,PDSP2_001375,Psilocin, phosphate ester,[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate,3-2'-Dimethylaminoethylindol-4-phosphate,2RV7212BP0,3-[2-(Dimethylamino)ethyl]indol-4-ol dihydrogen phosphate ester,Psylocybin,1H-Indol-4-ol, 3-(2-(dimethylamino)ethyl)-, dihydrogen phosphate (ester),Psilocybinum,({3-[2-(dimethylamino)ethyl]-1H-indol-4-yl}oxy)phosphonic acid,3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate #,EINECS 208-294-4,INDOL-4-OL, 3-(2-(DIMETHYLAMINO)ETHYL)-, DIHYDROGEN PHOSPHATE,CHEMBL194378,DEA No. 7437,Psilocin phosphate ester,CY-39,BDBM50171269,4-Phosphonooxy-N,N-dimethyltryptamine,PDSP1_001391,Psilocibina [INN-Spanish],HSDB 7365,4-HO-DMT phosphate ester,SB18760,N,N-Dimethyl-4-phosphoryloxytryptamine,3-[2-(Dimethylamino)ethyl]indol-4-yl dihydrogen phosphate,CHEBI:8614,PSILOCYBINE [INN],BRN 0273158,1H-Indol-4-ol, 3-[2-(dimethylamino)ethyl]-, dihydrogen phosphate,3-(2-Dimethylaminoethyl)indol-4-yl dihydrogen phosphate,Tryptamine, N,N-dimethyl-4-phosphoryloxy,CAS-520-52-5,Psilocibina,PSILOCYBINE [MART.],Psilocibin,DSSTox_GSID_48898,Cy 39,PSILOCYBINE [WHO-DD],DB11664,Q208118,PSOP,CY39,3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol dihydrogen phosphate ester,Psilotsibin,Psilocybine [INN:BAN:DCF],NCGC00247732-01,C07576,P-7825,PSILOCYBINE [HSDB],DTXSID0048898,1H-Indol-4-ol, 3-[2-(dimethylamino)ethyl]-, dihydrogen phosphate (ester),4-Indolol, 3-[2-(dimethylamino)ethyl], phosphate ester,Tox21_112898,4-Phosphoryloxy-omega-N,N-dimethyltryptamine,DTXCID0028824,4-PO-DMT,4-22-00-05665 (Beilstein Handbook Reference),4-Phosphoryloxy-N,N-dimethyltryptamine,Psilocybin,520-52-5,DSSTox_CID_28824,Psilocybinum [INN-Latin],PSILOCYBIN [MI],Indol-4-ol, 3-[2-(dimethylamino)ethyl]-, dihydrogen phosphate (ester),Teonanacatl,(3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-YL) DIHYDROGEN PHOSPHATE,3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate,UNII-2RV7212BP0,4-H2PO4-DMT,O-Phosphoryl-4-hydroxy-N,N-dimethyltryptamine

Estimated data

Solubility: -1.361 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 75.1% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.